Investigational Site Number :1240004

Edmonton, Alberta T6G 2C8

0 studies enrolling now · 4 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Breast Cancer, Myasthenia Gravis, Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer — Stopped early
• Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis — Stopped early
• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) — Stopped early